Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionScott & Selber, Inc.
Latest Disclosed Ownership3,384 shares
Latest Disclosed Value $ 1,190,610
Scott & Selber, Inc. reports 1.54% decrease in ownership of AMGN / Amgen Inc.

On April 16, 2026 - Scott & Selber, Inc. filed a 13F-HR form disclosing ownership of 3,384 shares of Amgen Inc. (MX:AMGN) valued at $1,190,610 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 9, 2026 disclosing 3,437 shares of Amgen Inc.. This represents a change in shares of -1.54% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-16 2026-03-31 13F AMGEN COM 031162100 3,384 -53 -1.54 1,191 5.87 0.3074
2026-01-09 2025-12-31 13F AMGEN COM 031162100 3,437 -150 -4.18 1,125 11.07 0.2821
2025-10-29 2025-09-30 13F/A-1 AMGEN COM 031162100 3,587 -42 -1.16 1,012 101,100.00 0.2578
2025-10-28 2025-09-30 13F AMGEN COM 031162100 3,585 -44 1,044 0.2560
2025-07-17 2025-06-30 13F Amgen COMM 031162100 3,629 28 0.78 1 0.00 0.2823
2025-04-24 2025-03-31 13F Amgen COMM 031162100 3,601 -2 -0.06 1 0.3592
2025-02-06 2024-12-31 13F Amgen COMM 031162100 3,603 4 0.11 1 -100.00 0.2826
2024-11-01 2024-09-30 13F Amgen COMM 031162100 3,599 -25 -0.69 1 0.00 0.3601
2024-07-29 2024-06-30 13F Amgen COMM 031162100 3,624 25 0.69 1 0.00 0.3610
2024-05-01 2024-03-31 13F Amgen COMM 031162100 3,599 -23 -0.64 1 0.00 0.3481
2024-02-01 2023-12-31 13F Amgen COMM 031162100 3,622 -20 -0.55 1 0.3912
2023-10-24 2023-09-30 13F Amgen COMM 031162100 3,642 -3 -0.08 1 0.4052
2023-07-28 2023-06-30 13F Amgen COMM 031162100 3,645 -13 -0.36 1 0.3163
2023-04-18 2023-03-31 13F Amgen COMM 031162100 3,658 12 0.33 1 0.3763
2023-01-31 2022-12-31 13F/A-1 Amgen COMM 031162100 3,646 -8 -0.22 1 -100.00 0.4306
2023-01-31 2022-12-31 13F Amgen COMM 031162100 3,646 -8 1 0.4306
2022-10-21 2022-09-30 13F Amgen COMM 031162100 3,654 17 0.47 824 -6.89 0.3970
2022-07-28 2022-06-30 13F Amgen COMM 031162100 3,637 -40 -1.09 885 -0.45 0.4034
2022-05-03 2022-03-31 13F Amgen COMM 031162100 3,677 -49 -1.32 889 6.09 0.3426
2022-02-04 2021-12-31 13F Amgen COMM 031162100 3,726 3,726 838 0.2972
2019-07-31 2019-06-30 13F Amgen COMM 031162100 0 -14,848 -100.00 0 -100.00
2019-05-03 2019-03-31 13F Amgen COMM 031162100 14,848 -36 -0.24 2,821 -2.62 1.4756
2019-02-01 2018-12-31 13F Amgen COMM 031162100 14,884 -365 -2.39 2,897 -8.35 1.7667
2018-10-29 2018-09-30 13F Amgen COMM 031162100 15,249 -4 -0.03 3,161 12.25 1.5552
2018-07-24 2018-06-30 13F Amgen COMM 031162100 15,253 82 0.54 2,816 8.89 1.5114
2018-05-08 2018-03-31 13F Amgen COMM 031162100 15,171 -376 -2.42 2,586 -4.36 1.4558
2018-02-01 2017-12-31 13F Amgen COMM 031162100 15,547 -79 -0.51 2,704 -7.17 1.4462
2017-11-06 2017-09-30 13F Amgen COMM 031162100 15,626 -312 -1.96 2,913 6.12 1.6825
2017-08-08 2017-06-30 13F Amgen COMM 031162100 15,938 -314 -1.93 2,745 2.96 1.6584
2017-04-26 2017-03-31 13F Amgen COMM 031162100 16,252 -16 -0.10 2,666 12.06 1.6257
2017-02-01 2016-12-31 13F Amgen COMM 031162100 16,268 -60 -0.37 2,379 -12.67 1.5302
2016-10-28 2016-09-30 13F Amgen COMM 031162100 16,328 90 0.55 2,724 10.24 1.7167
2016-07-29 2016-06-30 13F Amgen COMM 031162100 16,238 70 0.43 2,471 1.94 1.6561
2016-05-02 2016-03-31 13F Amgen COMM 031162100 16,168 16,168 0.00 2,424 1.6218
2016-01-26 2015-12-31 13F Amgen COMM 031162100 0 -1,615 -100.00 0 -100.00
2015-10-19 2015-09-30 13F Amgen COMM 031162100 1,615 1,615 223 0.1650
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.